|
Description:
|
|
Today we’re joined by Jannis Born, Ph.D. student at ETH & IBM Research Zurich. We caught up with Jannis a few weeks back at NeurIPS, to discuss: - His research paper “PaccMann^RL: Designing anticancer drugs from transcriptomic data via reinforcement learning,” a framework built to accelerate new anticancer drug discovery.
- How his background in cognitive science and computational neuroscience applies to his current ML research.
- How reinforcement learning fits into the goal of cancer drug discovery, and how deep learning has changed this research.
- Jannis describes a few interesting observations made during the training of their DRL learner.
- And of course, Jannis offers us a step-by-step walkthrough of how the framework works to predict the sensitivity of cancer drugs on a cell and subsequently discover new anticancer drugs.
Check out the complete show notes for this episode at twimlai.com/talk/341. |